Evidence map›Paper›PMID 24874661›Full record

ArticlePloS one2014

Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis.

Samuel A Curran, Ivana Hollan, Clett Erridge, David F Lappin, Colin A Murray, Gunnar Sturfelt, Knut Mikkelsen, Oystein T Førre, Sven M Almdahl, Magne K Fagerhol and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Promising Adventitia in Atherosclerosis.Current vascular pharmacology · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. The association between bacteria and urinary stones.Annals of translational medicine · 2017
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Samuel A CurranDental School, University of Glasgow, Glasgow, United Kingdom.
Ivana HollanHospital for Rheumatic Diseases, Lillehammer, Norway, and Feiring Heart Clinic, Feiring, Norway.
Clett ErridgeDepartment of Cardiovascular Sciences, University of Leicester, Glenfield General Hospital, Leicester, United Kingdom.
David F LappinDental School, University of Glasgow, Glasgow, United Kingdom.
Colin A MurrayDental School, University of Glasgow, Glasgow, United Kingdom.
Gunnar SturfeltDepartment of Rheumatology, Lund University Hospital, Lund, Sweden.
Knut MikkelsenHospital for Rheumatic Diseases, Lillehammer, Norway.
Oystein T FørreDepartment of Rheumatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Sven M AlmdahlDepartment of Surgery, University Hospital of North Norway, Tromsø, Norway.
Magne K FagerholDepartment of Immunology and Transfusion Medicine, Ullevaal University Hospital, Oslo, Norway.
Carl S GoodyearInstitute of Infection Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Marcello P RiggioDental School, University of Glasgow, Glasgow, United Kingdom.
University of Glasgow · GBOslo University Hospital · NOLund University · SEUniversity Hospital of North Norway · NOUniversity of Leicester · GB

Funding

Arthritis Research UK 19701Medical Research Council
6 · The paper itself

Abstract

The incidence of atherosclerosis is significantly increased in rheumatoid arthritis (RA). Infection is one factor that may be involved in the pathogenesis of both diseases. The cause of RA and atherosclerosis is unknown, and infection is one of the factors that may be involved in the pathogenesis of both diseases. The aims of this study were to identify bacteria in the aortic adventitia of patients with cardiovascular disease (CVD) in the presence and absence of RA, and to determine the effect of identified candidate pathogens on Toll-like receptor (TLR)-dependent signalling and the proinflammatory response. The aortic adventitia of 11 CVD patients with RA (RA+CVD) and 11 CVD patients without RA (CVD) were collected during coronary artery bypass graft surgery. Bacteria were detected in four samples from CVD patients and three samples from RA+CVD patients and identified by 16S rRNA gene sequencing. Methylobacterium oryzae was identified in all three RA+CVD samples, representing 44.1% of the bacterial flora. The effect of M. oryzae on TLR-dependent signalling was determined by transfection of HEK-293 cells. Although mild TLR2 signalling was observed, TLR4 was insensitive to M. oryzae. Human primary macrophages were infected with M. oryzae, and a TLDA qPCR array targeting 90 genes involved in inflammation and immune regulation was used to profile the transcriptional response. A significant proinflammatory response was observed, with many of the up-regulated genes encoding proinflammatory cytokines (IL-1α, IL-1β, IL-6, TNF-α) and chemokines (CCR7, IL-8). The aortic adventitia of CVD patients contains a wide range of bacterial species, and the bacterial flora is significantly less diverse in RA+CVD than CVD patients. M. oryzae may stimulate an proinflammatory response that may aggravate and perpetuate the pathological processes underlying atherosclerosis in RA patients.

Indexed as

BacteriaAdventitiaAgedAortaArthritis, RheumatoidCardiovascular DiseasesCytokinesFemaleHumansInflammation MediatorsLeukocyte L1 Antigen ComplexMacrophagesMaleMiddle AgedMycobacteriumMycobacterium InfectionsCytokinesInflammation MediatorsLeukocyte L1 Antigen ComplexRNA, BacterialRNA, Ribosomal, 16SToll-Like Receptors

Identifiers

PMID24874661
PMCPMC4038603
OpenAlexW2071290155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.